As the COVID-19 pandemic continues to disrupt our daily lives, the clinical research industry knows full well that despite these challenges, we can't put our highest calling — protecting human subjects — on hold. Instead, we have to adjust how we do our daily jobs in order to fulfill this ethical responsibility. This will most likely mean changes in your protocol, monitoring plans, data management plans, BIMO-prep activities and other study-related activities.
We can help you take proactive steps to keep your trial moving forward during this uncertain time. That may include implementing remote monitoring, modifying your protocol to address safety concerns, hosting virtual training for your team or conducting an electronic review of your Trial Master File.
As you work with your study teams to make adjustments, I would encourage you to reach out to us if we can help in any way. This is what we do every single day.
IMARC has long subscribed to the thought that historical events have been our best instructor in guiding our daily ethical practices. Right now, we are living through something historical. Those that come after us will look back on this time, analyze our actions or inactions, and determine whether we succeeded or failed. We value our partnerships with each of you and want to help see these studies through to the other side of this.
Let's work together to end up on the right side of history.
